1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Hereditary Spastic Paraparesis: new trials by email Literature Review of Hereditary Spastic Paraparesis trials Research Report on Hereditary Spastic Paraparesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) BFB-101 (AAV9-CBh-AP4B1) - HSP, Hereditary Spastic Paraplegia | Phase 1 / Phase 2 | Not yet recruiting | BlackfinBio Ltd | 5 | 2025-08-01 | 2025-04-28 |
| Testing Miglustat Administration in Subjects With Spastic Paraplegia 11 Miglustat 100 MG - Hereditary Spastic Paraparesis | Phase 2 | Completed | IRCCS Fondazione Stella Maris | 10 | 2021-06-15 | 2022-04-11 |
Spastic Paraplegia, Hereditary (2) · Movement Disorders (1) · Muscle Spasticity (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hereditary Sensory and Motor Neuropathy (2) · Heredodegenerative Disorders, Nervous System (2) · Nervous System Diseases (2) · Nervous System Malformations (2) · Neurodegenerative Diseases (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2) · Polyneuropathies (2) · Central Nervous System Diseases (1) · Muscle Hypertonia (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1)
miglustat (1)
BlackfinBio Ltd (1) · IRCCS Fondazione Stella Maris (1)
Italy (1) · United States (1)
Filippo M Santorelli, MD PhD (1)
2019 (1)